Remove Biopharma Remove Healthcare Remove Physicians Remove Prescription
article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.

Retail 52
article thumbnail

Veradigm® Digital Health Media Works to Message the Right Physicians at the Right Time

PM360

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks. THE CHALLENGE.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Five ways COVID-19 has changed healthcare provision and what it means for pharmas

Clarivate

As the COVID-19 pandemic continues to evolve, we are seeing substantial shifts in the way patients access healthcare and how providers deliver care. 2021 surveys of patients and physicians in the United States conducted by Clarivate show that: Much of care delivery has gone virtual. hours seeing patients.

Pharma 52
article thumbnail

Five points on CMS’s first ten picks for price negotiations

Clarivate

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. In both cases, a shift in formulary placement could lower prescription volumes and reduce member utilization. With 27.5% exclusions exist for orphan drug designation and biosimilar competition ).

article thumbnail

The AMJEVITA impact: Innovative U.S. biosimilar pricing models

Clarivate

biologics market and reduce prescription drug costs. and European physicians across six specialties, and global pipeline analysis curated by experts to provide insights into the evolving landscape. By end of year, as many as ten adalimumab biosimilars could be on the U.S. In 2022, it made its manufacturer, AbbVie, $21.2bn.

article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. Communication and follow-up with the physician. Prescription refill and renewal. Patient monitoring for safety and efficacy.

article thumbnail

Accelerating HCP engagement in Singapore using customer reference data

Veeva

Veeva OpenData has one of the most accurate customer reference data sets available in the market and provides access to a wide profile of healthcare professionals and healthcare organisations in Singapore. This enables field reps to target the right physicians and opportunities in real time. Streamline compliance.

Sales 52